Study Stopped
Due to COVID-19, this pilot study ended prematurely.
Patient-based Care Versus Standard Care for Patients With hEDS/HSD and Multidirectional Shoulder Instability
Effectiveness of a 6-month Home-based Exercise Program for Treating Shoulder Instability in Patients With Hypermobile Ehlers-Danlos Syndrome (hEDS) or Hypermobility Spectrum Disorder (HSD): A Pilot Randomized Controlled Trial.
2 other identifiers
interventional
21
1 country
1
Brief Summary
For hEDS or HSD patients with MDI, a multidisciplinary treatment approach is suggested. As follows, physiotherapy plays a key role in this integrative management. Nevertheless, knowledge regarding EDS is limited among health care professionals. Consequently, evidence-based treatment approaches for the hEDS/HSD population are scarce. Therefore, the aim of this study is to compare two different home-based exercise programs in order to increase our knowledge regarding treatment options, and to gain insight in safe, effective exercises for the unstable shoulder in this study population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 9, 2020
CompletedFirst Submitted
Initial submission to the registry
December 8, 2020
CompletedFirst Posted
Study publicly available on registry
December 14, 2020
CompletedMarch 22, 2021
March 1, 2021
1.2 years
December 8, 2020
March 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Western Ontario Shoulder Instability Index (WOSI)
The WOSI is a responsive patient-reported and disease-specific tool, designed to be used as the primary outcome measure in clinical trials that assess treatments for patients with shoulder instability. Range 0 - 2100 points. Higher scores express worse status.
Measured at baseline, 6 weeks, 12 weeks and 24 weeks, in order to assess the change in WOSI from baseline to 6 weeks, 12 weeks, and 24 weeks
Secondary Outcomes (5)
The Disabilities of the Arm Shoulder and Hand (DASH)
Measured at baseline, 6 weeks, 12 weeks and 24 weeks
The Tampa Scale for Kinesiophobia (TSK)
Measured at baseline, 6 weeks, 12 weeks and 24 weeks
The Patient-Specific Functional Scale (PSFS)
Measured at baseline, 6 weeks, 12 weeks and 24 weeks
The Global Rating of Change (GROC)
Measured at baseline, 6 weeks, 12 weeks and 24 weeks
Pain pressure thresholds (PPT)
Measured at baseline, 6 weeks, 12 weeks and 24 weeks
Study Arms (2)
Evidence-based tailored care (group A)
EXPERIMENTALPatients who were randomized to group A received a tailored exercise program, with exercises developed based on recent hEDS/HSD research data.
Evidence-based standard care (group B)
ACTIVE COMPARATORThis exercise program was composed in order to reflect evidence-based standard care, in a telerehabilitation format.
Interventions
exercises were divided into four types: 1) shrug exercises; 2) external rotation exercises; 3) bench slides; and 4) wall slides.
The exercise program consisted of 4 types of exercises for training 1) balance and proprioception; 2) isometric strength; 3) rotator cuff muscles; and 4) open chain elevation
Eligibility Criteria
You may qualify if:
- Female
- years
- Patients diagnosed by a medical doctor with generalized HSD or hEDS, according to the diagnostic criteria for hEDS and HSD as stated in the recently published international classification for the Ehlers-Danlos syndromes
- Patients diagnosed with multidirctional shoulder instability (MDI): The diagnosis of MDI was confirmed when 1) patients reported symptoms of shoulder instability in daily life (e.g. recurrent subluxations) without a traumatic onset; 2) patients scored positive on shoulder laxity and instability tests (i.e. sulcus sign, anterior and posterior load and shift, posterior jerk, Gagey hyperabduction test, passive and active external rotation in supine, apprehension and relocation test) in at least two directions; 3) patients had shoulder pain for at least three months prior to the study.
You may not qualify if:
- pregnancy during study participation
- patients who started a new physiotherapeutic treatment in the 2 weeks prior to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
Ghent University, department of rehabilitation sciences
Ghent, Oost-Vlaanderen, 9000, Belgium
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Fransiska Malfait, Prof. Dr.
Centre of Medical Genetics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2020
First Posted
December 14, 2020
Study Start
May 9, 2019
Primary Completion
July 9, 2020
Study Completion
July 9, 2020
Last Updated
March 22, 2021
Record last verified: 2021-03